CMPS
COMPASS Pathways PlcAbout CMPS
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
Moved with Pharmaceuticals peers: ABCL −8.30% · AXSM −8.11% · SMMT −7.11%
From market data · Not investment advice
Moved with Pharmaceuticals peers: ABCL −8.30% · AXSM −8.11% · SMMT −7.11%
From market data: the larger companies in its group moved the same way. No report names a cause yet.
Last check 3:00 PM ET
From market data · Not investment adviceSign up free to see this.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Sentiment
No sentiment yet
Votes and Bull · Bear posts, 24h. At least 5 are needed.
How do you feel about CMPS?
Board · 0 threads
Open board ›No threads yet
Community opinions, not advice. Posts with a target get a receipt. How receipts work ›